Baillie Gifford & Co. Decreases Stock Position in Xylem Inc. (NYSE:XYL)

Key Points

• Baillie Gifford & Co. has decreased its stock position in Xylem Inc. by 22.5%, owning around 1,269,337 shares after selling 369,186 shares in Q1.
• A number of other hedge funds have recently altered their stakes in Xylem, with Valley National Advisers Inc. increasing its holdings by 84.9% during the same period.
• Xylem reported an EPS of $1.03 for the last quarter, surpassing analyst estimates and showing a 1.8% year-over-year revenue increase.

Baillie Gifford & Co. reduced its position in Xylem Inc. (NYSE:XYL - Free Report) by 22.5% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,269,337 shares of the industrial products company's stock after selling 369,186 shares during the period. Baillie Gifford & Co. owned about 0.52% of Xylem worth $151,635,000 at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in XYL. Valley National Advisers Inc. raised its holdings in Xylem by 84.9% in the 1st quarter. Valley National Advisers Inc. now owns 220 shares of the industrial products company's stock worth $26,000 after acquiring an additional 101 shares during the last quarter. Perkins Coie Trust Co purchased a new stake in Xylem during the 1st quarter valued at $27,000. Center for Financial Planning Inc. raised its stake in Xylem by 52.0% during the 1st quarter. Center for Financial Planning Inc. now owns 266 shares of the industrial products company's stock valued at $32,000 after buying an additional 91 shares during the last quarter. Heck Capital Advisors LLC purchased a new stake in Xylem during the 4th quarter valued at $36,000. Finally, Financial Gravity Asset Management Inc. purchased a new stake in Xylem during the 1st quarter valued at $41,000. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Xylem Trading Down 0.4%

NYSE:XYL opened at $131.28 on Friday. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.89 and a quick ratio of 1.41. The firm has a market capitalization of $31.95 billion, a price-to-earnings ratio of 35.29, a price-to-earnings-growth ratio of 2.39 and a beta of 1.12. Xylem Inc. has a one year low of $100.47 and a one year high of $143.50. The business has a fifty day moving average price of $128.31 and a 200-day moving average price of $123.45.

Xylem (NYSE:XYL - Get Free Report) last posted its quarterly earnings data on Tuesday, April 29th. The industrial products company reported $1.03 EPS for the quarter, topping the consensus estimate of $0.95 by $0.08. The firm had revenue of $2.07 billion during the quarter, compared to analyst estimates of $2.04 billion. Xylem had a return on equity of 10.12% and a net margin of 10.54%. Xylem's revenue was up 1.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.90 EPS. Sell-side analysts forecast that Xylem Inc. will post 4.65 EPS for the current year.

Xylem Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, June 26th. Shareholders of record on Thursday, May 29th were paid a $0.40 dividend. The ex-dividend date was Thursday, May 29th. This represents a $1.60 dividend on an annualized basis and a yield of 1.22%. Xylem's payout ratio is presently 43.01%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on XYL shares. JPMorgan Chase & Co. started coverage on shares of Xylem in a research note on Friday, May 30th. They set an "overweight" rating and a $148.00 target price for the company. Royal Bank Of Canada boosted their target price on shares of Xylem from $143.00 to $147.00 and gave the company an "outperform" rating in a research note on Wednesday, April 30th. Citigroup reiterated a "buy" rating and set a $152.00 target price (up from $137.00) on shares of Xylem in a research note on Monday, July 14th. Robert W. Baird decreased their target price on shares of Xylem from $149.00 to $146.00 and set an "outperform" rating for the company in a research note on Wednesday, April 30th. Finally, Raymond James Financial upgraded shares of Xylem to a "hold" rating in a research note on Thursday, May 15th. Three research analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to data from MarketBeat.com, Xylem currently has a consensus rating of "Moderate Buy" and an average price target of $149.29.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.